Jake
Jordan, PhD

Jake Jordan, PhD serves as vice president of NTI’s Global Biological Policy and Programs (NTI | bio). In this role, he leads a portfolio of projects working with governments, industry, academia, and NGOs to foster new thinking, test solutions, and promote systemic changes to improve biosecurity and reduce biological risks.

Throughout his career, Jordan has worked at the intersection of biotechnology, national security, and emerging technology, helping senior leaders translate organizational and technical concepts into executable strategies and research and development programs. He has served in senior advisory roles for Defense Advanced Research Projects Agency (DARPA) and Advanced Research Projects Agency for Health (ARPA-H) Program Managers (PMs), the DARPA Biological Technologies Office (BTO) Director, and the ARPA-H Director. Jordan also supported Operation Warp Speed, assisting an interagency Program Coordination Team tracking status and driving performance towards Emergency Use Authorization (EUA) for a government-funded vaccine candidate.

Before re-joining NTI in March 2026, Jordan most recently led the execution of a $400M portfolio of scientific, engineering, and professional consulting services contracts. From 2018-2020, he served as a senior director on the NTI | bio team, where he launched and led NTI’s Biosecurity Innovation and Risk Reduction Initiative (BIRRI) and helped drive international efforts to reduce biological risks associated with advances in technology.

Jordan earned a PhD and MS in Chemical Engineering from the University of Virginia and a BE in Chemical Engineering from Vanderbilt University. He has published nine peer-reviewed articles in leading scientific journals, including Science and Nature Communications, generating more than 300 citations.